Proactive - Interviews for investors

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Strickland Metals Ltd (ASX:STK).

The company has received another thick, high-grade intersection from ongoing drilling at the Medenovac Prospect, part of its Rogozna Gold and Base Metals Project in Serbia.

Recent diamond drilling revealed 43.4 metres at 4.6 g/t gold equivalent within a larger 233-metre section at 1.7 g/t gold equivalent. Included in this is a 19.7-metre interval at 6.8 g/t gold equivalent, highlighting extensive high-grade gold and base metal mineralisation.

Medenovac, one of four skarn-hosted deposits within Rogozna, shows consistent mineralisation over a 150-metre strike length.

These latest results provide Strickland Metals with the data needed to proceed with a maiden mineral resource estimate for the site, planned for early next year.

Strickland remains well-capitalised, holding more than $14 million in cash and Northern Star Resources shares as of September 30. Drilling continues at Rogozna with four active rigs and the company is awaiting additional assay results from other drill holes.

#ProactiveInvestors #StricklandMetals #ASX #JusttheFacts #GoldDiscovery #RogoznaProject #MedenovacProspect #GoldMining #BaseMetals #SerbiaMining #HighGradeIntercept #ExplorationDrilling #MiningUpdate #ResourceEstimate #GoldCopperZinc #Mineralisation #MiningExploration #ASX #DrillResults #MiningIndustry #MetalResources #MiningProjects #Gold

Gold Hydrogen Ltd (ASX:GHY) managing director Neil McDonald joins Proactive’s Tylah Tully to discuss the company’s latest discovery.

In collaboration with Oxford University, it has identified Helium-3, a rare isotope essential for nuclear fusion, at its Ramsay Project in South Australia.

Helium-3, which is valued at more than $2,500 per litre, holds critical applications in nuclear fusion, quantum computing and advanced cryogenics, given its neutron absorption properties.

Previously, this isotope was only accessible via nuclear by-products or costly extraterrestrial mining initiatives.

Samples from Ramsay, drawn from depths of 280 to 1,000 metres, showed Helium-3 concentrations reaching 901 ppt with purity levels as high as 36.9%, some of the highest globally recorded.

This finding could provide an accessible, Earth-based supply of Helium-3, mitigating the need for costly lunar mining.

Gold Hydrogen is furthering research on Ramsay’s reserves, including flow rates and geotechnical analysis, with aims to enhance separation methods for Helium-3 and Helium-4.

This development aligns with increasing global support for fusion energy, as commercial interest in this clean, sustainable power source accelerates.

Strategic partnerships are underway to scale Helium-3 recovery, potentially positioning Ramsay as a premier site for fusion-related resources.

#ProactiveInvestors #GoldHydrogen #Helium3 #NuclearFusion #RamsayProject #OxfordUniversity #CleanEnergy #QuantumComputing #RareIsotope #FusionTechnology #StockSurge #EnergyResearch #GlobalEnergy #RenewableResources #Cryogenics #IsotopeDiscovery #SouthAustralia #NuclearInnovation #EnergyFuture #SustainableTech #Fusion

Tiziana Life Sciences CEO Ivor Elrifi joined Steve Darling from Proactive to share news the company has announced positive research findings showing the anti-inflammatory potential of the company’s nasal anti-CD3 antibody, foralumab, when used in combination with semaglutide, a GLP-1 agonist marketed as Ozempic and Wegovy. The study, conducted by Dr. Howard Weiner, Selma Boulenouar, PhD, and their team at Brigham and Women’s Hospital, shows the combination significantly improves liver function and reduces inflammation in diet-induced obesity models.

The data reveal that nasal anti-CD3 combined with semaglutide not only promotes liver homeostasis but also markedly decreases pro-inflammatory cytokines, suggesting a promising, multifaceted approach to managing obesity and its challenging complications. These findings underline the potential of this therapy as a breakthrough in addressing both obesity and its often treatment-resistant metabolic effects.

#proactiveinvestors #tizianalifescienceslts #nasdaq #tlsa #newceo #ivorelrifi

#Foralumab #Ozempic #InflammationResearch #MonoclonalAntibody #BiotechNews #IvorElrifi #ClinicalResearch #SPMS #AlzheimersResearch #GLP1 #ProactiveInvestors#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Ananda Developments Finance Director Jeremy Sturgess-Smith joined Steve Darling from Proactive to share some of the key milestones achieved by the company in its interim results for February 1, 2024, to July 31, 2024. During this period, Ananda has advanced its patent-pending MRX1 CBD formulation in two fully funded Phase II trials for chemotherapy-induced nerve pain and endometriosis.

Sturgess-Smith also noted the selection of Ananda's MRX2 and MRX2T CBD and CBD + THC formulations for two groundbreaking Phase III trials. These will be the world's first double-blind, randomized controlled trials (RCTs) to examine the combined use of CBD and THC for epilepsy, specifically challenging-to-treat cases in both children and adults. Conducted across multiple NHS sites, these trials aim to enroll 500 patients over 18 months to test the effects of CBD, a CBD/THC combination, and a placebo.

Following the reporting period, Ananda's MRX1 CBD formulation will undergo a Phase I pharmacokinetic assessment. Additionally, preclinical studies on MRX1 have shown positive results for heart fibrosis treatment potential, part of the company’s efforts to establish a robust preclinical pipeline. To support these initiatives, Ananda completed a successful capital raise and announced the formation of a Scientific Advisory Board led by Professor Clive Page.

#proactiveinvestors #anandadevelopmentsplc #aqse #ana

#MRXFormulations #EpilepsyResearch #ClinicalTrials #HealthcareInnovation #CannabinoidResearch #NHS #Pharmaceuticals #Investing #ProactiveInvestors

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Tolu Minerals CEO Iain Macpherson joined Steve Darling from Proactive to share news that the company has successfully raised A$26.7 million through a heavily backed placement, with strong demand from both new and existing institutional and sophisticated investors, domestically and internationally.

This funding will enable Tolu Minerals to advance exploration at the Tolukuma Gold Mine, supporting redevelopment efforts, including study work, mine development, and dewatering.

Macpherson also provided insights into preliminary findings from Phase 1 of the company’s Airborne Mobile Magneto Telluric (MT) survey, covering 723 km², including ML 104 and surrounding exploration licenses. Results reveal advanced copper-gold porphyry and gold epithermal targets primed for drill testing.

Within ML 104, a significant conductivity anomaly demonstrates mineralization continuity extending over 2 km south of the mine site. Additionally, the Belavista target, located approximately 10 km west of Tolukuma, shows historical samples with high-grade readings, suggesting promising porphyry mineralization. These findings mark a pivotal moment for Tolu Minerals, as newly identified mineralized areas around Tolukuma are prepared for immediate drill testing.

#proactiveinvestors #tolumineralslimited #asx #tok

#GoldMining #Exploration #MiningInvestment #PapuaNewGuinea #ResourceDevelopment #IainMacpherson #ProactiveInvestors #MiningUpdates #GoldProduction

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Helix Exploration Chairman David Minchin joined Steve Darling from Proactive to announce the start of drilling at the Rudyard Project in Montana with the Darwin #1 well. This well aims to explore the stacked reservoir targets within the Souris, Red River, and Dry Creek intervals, where historical drilling has shown helium flow rates of up to 1.3% and estimated contingent resources of approximately 484,193 Mcf across the Souris and Red River intervals.

Minchin confirmed that Helix is fully funded to support both the drilling and testing phases of Darwin #1 at Rudyard, running alongside extended well testing at Clink #1 on Ingomar Dome. Drilling is expected to take 2-3 weeks, followed by detailed wireline logging and extended flow tests. Helix plans to update investors on significant developments, including helium gas concentrations, wireline findings, initial flow tests, and extended well test results.

#proactiveinvestors #helixexplorationplc #aim #hex #HeLIXExploration #EnergyUpdate #HeliumMarket #HydrogenExploration #KlinkWell #NaturalGas #ChipManufacturing #ProactiveInterview HeliumDiscovery #MontanaDrilling #RudyardProject #DavidMinchin #ProactiveInvestors #EnergyExploration #HeliumProduction #NaturalResources #Investing#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Arizona Gold and Silver CEO Mike Stark joined Steve Darling from Proactive to share an exciting update on the company's Philadelphia Project, where they’ve commenced a 40-hole drill program aimed at confirming high-grade mineralization. The exploration is split between two main drilling pads, with up to 20 holes planned per pad. Stark highlighted that Pad 1 will target depths between 800 to 1,000 feet, with flexibility for deeper drilling based on initial results, particularly as Pad 2 sits 600 meters north and may reveal additional findings.

Stark emphasized that the drill sites benefit from excellent access due to well-maintained roadways, allowing the team to focus on exploration without major infrastructure modifications. Referring to the project’s potential as a "TSN turning point," Stark expressed optimism in proving up a hypothesis four years in the making. “It’s a very exciting time for the company,” he remarked, as Arizona Gold & Silver works to unlock the site's mineralization potential.

#proactiveinvestors #arizonagoldandsilverinc #tsxv #azs #otcqb #azasf #MiningUpdates #GoldExploration #PhiladelphiaProject #MiningDrilling #GoldAndSilver

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

FireFly Metals Ltd (ASX:FFM) managing director Steve Parson sits down with Proactive’s Tylah Tully to discuss a 42% increase in the mineral resource estimate (MRE) for its Green Bay Copper-Gold Project in Newfoundland, Canada, following an extensive 2023-2024 drilling program.

The MRE now stands at 59 million tonnes at 2% copper equivalent (CuEq), representing 1.2 million tonnes of contained metal. Key resources include 1 million tonnes of copper, 550,000 ounces of gold and 5.4 million ounces of silver, marking increases of 39%, 48% and 57% for each metal, respectively.

The resource expansion, achieved through 40,000 metres of diamond drilling, confirms Green Bay’s status as a high-grade copper project.

FireFly's discovery cost averaged A$79 per tonne of CuEq, making it a cost-effective asset.

The Green Bay Project includes a high-grade volcanogenic massive sulphide (VMS) zone, now estimated at 6 million tonnes at 4.3% CuEq, and shows potential for further expansion based on recent geophysical data.

FireFly, with recent funding of A$73 million, is positioned to continue its drilling and engineering efforts into 2025, targeting additional resource growth in VMS and copper stringer zones.

The next drilling phase is underway with step-out results expected in the coming weeks.

#ProactiveInvestor #FireFlyMetals #ASX #GreenBayProject, #CopperGoldMining, #MineralResource, #HighGradeCopper, #VMSZones, #MiningCanada, #MineralExploration, #CopperGrowth, #SteveParsons, #LowCostDiscovery, #GoldCoProducts, #ResourceExpansion, #UndergroundMining, #DiamondDrilling, #GeophysicalSurvey, #MultiRigDrilling, #MiningInvestment, #BulkMining, #MiningPotential

Tryptamine Therapeutics Ltd (ASX: TYP) CEO Jason Carroll joins Proactive’s Tylah Tully to talk through $6 million the company has secured through a strategic placement of 300 million new shares at $0.02 each.

The placement was supported by new and existing stakeholders, including cornerstone investors, the Merchant Biotech Fund and Dr Daniel Tillett, who will join the board as a non-executive director.

Key shareholders and company executives, including Carroll himself, also participated.

The funds will facilitate the accelerated clinical development of TRP-8803, an IV-infused psilocin formulation designed to address limitations associated with oral psilocybin dosing.

Benefits of TRP-8803 include faster onset, more controlled dosing and shorter intervention times. This aligns with Tryp’s ongoing efforts to explore the compound’s therapeutic potential in treating various conditions.

The recent Phase 1b study confirmed TRP-8803’s safety, bolstering plans for larger trials and potential product registration in Australia.

The placement, scheduled in two tranches, will enable Tryp to advance its clinical strategy. Merchant Group acted as lead manager for the placement, with shareholder approvals anticipated for tranche two in an upcoming General Meeting.

#ProactiveInvestors #TrypTherapeutics #ASX #ClinicalTrials, #Psilocin, #PsychedelicTherapy, #TRP8803, #Psilocybin, #MentalHealth, #BiotechNews, #Pharmaceuticals, #HealthInnovation, #MedicalResearch, #BiotechFunding, #ASXNews, #PsychiatricDisorders, #Investment, #BioPharma, #MedicalTrials, #DrugDevelopment, #IVTherapy, #HealthSolutions

Orion Minerals Ltd (ASX: ORN, JSE:ORN) managing director and CEO Errol Smart joins Proactive’s Tylah Tully to discuss progress on feasibility studies for the Prieska Copper-Zinc Mine (PCZM) and Okiep Copper Project (OCP) in South Africa’s Northern Cape.

This comes as the company appointed Nick Fouche as PCZM project director and LMMS Consultants for optimisation work.

Fouche, a seasoned mining executive with experience in developing significant mining projects, previously led Palabora Mining Company’s growth. His role at Orion focuses on optimising PCZM’s design and scheduling.

Australian-based LMMS Consultants, experienced in international and South African projects, will assist in refining the PCZM feasibility study, aiming to improve mine scheduling and design through expert guidance.

Key LMMS consultants Joe Luxford and Doug Syme have been instrumental in similar South African projects, contributing experience in the local operational landscape.

A recent internal review of PCZM identified potential enhancements through optimisation with the ongoing work set for completion this quarter.

The optimised feasibility study is now expected in early 2025.

Smart emphasised the importance of optimising the mine design to enhance ore recovery and financial returns.

Concurrently, the feasibility study for OCP’s Flat Mines Project remains on schedule for review in November 2024, with delivery by year-end.

#ProactiveInvestors #OrionMinerals #ASX #JSE #MiningUpdates, #CopperZincMining, #PrieskaProject, #OkiepProject, #FeasibilityStudy, #NorthernCapeMining, #NickFouche, #LMMSConsultants, #SouthAfricanMining, #MineOptimisation, #CopperMining, #ZincMining, #ProjectDevelopment, #ErrolSmart, #MiningIndustry, #Engineering, #MiningConsultants, #ResourceOptimisation, #LongTermMining